SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-017826
Filing Date
2019-09-12
Accepted
2019-09-12 08:09:57
Documents
15
Period of Report
2019-09-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k091219_amagpharma.htm   iXBRL 8-K 24351
2 PRESS RELEASE ISSUED BY AMAG PHARMACEUTICALS, INC. ON SEPTEMBER 12, 2019 f8k091219ex99-1_amag.htm EX-99.1 19514
6 GRAPHIC ex99-1_001.jpg GRAPHIC 9810
7 GRAPHIC image_001.jpg GRAPHIC 14468
  Complete submission text file 0001213900-19-017826.txt   277601

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE amag-20190912.xsd EX-101.SCH 3182
4 XBRL LABEL FILE amag-20190912_lab.xml EX-101.LAB 34581
5 XBRL PRESENTATION FILE amag-20190912_pre.xml EX-101.PRE 22704
9 EXTRACTED XBRL INSTANCE DOCUMENT f8k091219_amagpharma_htm.xml XML 3624
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 191089542
SIC: 2834 Pharmaceutical Preparations